These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2537556

  • 1. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
    Jamison M, Widerhorn J, Weber L, Campese V, Vasquez J, Hovanessian L, Rahimtoola SH, Elkayam U.
    Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
    Leier CV, Binkley PF, Carpenter J, Randolph PH, Unverferth DV.
    Am J Cardiol; 1988 Jul 01; 62(1):94-9. PubMed ID: 2898209
    [Abstract] [Full Text] [Related]

  • 3. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure.
    Ungar A, Fumagalli S, Marini M, Di Serio C, Tarantini F, Boncinelli L, Baldereschi G, Valoti P, La Cava G, Olianti C, Masotti G, Marchionni N.
    Crit Care Med; 2004 May 01; 32(5):1125-9. PubMed ID: 15190961
    [Abstract] [Full Text] [Related]

  • 4. [Dopexamine: a new dopaminergic agonist].
    Perrin G, Papazian L, Martin C.
    Ann Fr Anesth Reanim; 1993 May 01; 12(3):308-20. PubMed ID: 7902685
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic and renal effects of dopexamine after cardiac surgery in children.
    Habre W, Beghetti M, Roduit C, Girardin E, Vallotton M, Friedli B, Berner M.
    Anaesth Intensive Care; 1996 Aug 01; 24(4):435-9. PubMed ID: 8862639
    [Abstract] [Full Text] [Related]

  • 6. Human renovascular effects of dopexamine hydrochloride: a novel agonist of peripheral dopamine and beta 2-adreno-receptors.
    Magrini F, Foulds R, Roberts N, Macchi G, Mondadori C, Zanchetti A.
    Eur J Clin Pharmacol; 1987 Aug 01; 32(1):1-4. PubMed ID: 2884113
    [Abstract] [Full Text] [Related]

  • 7. Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
    Lang RM, Borow KM, Neumann A, Carroll JD, Weinert L, Murphy MB, Ghali J, Rajfer SI.
    Am J Cardiol; 1988 Aug 11; 62(5):46C-52C. PubMed ID: 2841838
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failure.
    Svensson G, Sjögren A, Erhardt L.
    Eur Heart J; 1986 Aug 11; 7(8):697-703. PubMed ID: 2876894
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
    Tan LB, Littler WA, Murray RG.
    Int J Cardiol; 1991 Feb 11; 30(2):203-8. PubMed ID: 2010243
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure.
    Colardyn FA, Vandenbogaerde JF.
    Am J Cardiol; 1988 Aug 11; 62(5):68C-72C. PubMed ID: 3407598
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.